MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.43

-0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	5/31/2007 1:55:48 AM
	of 2240

Celldex Therapeutics Announces Poster Presentations of Lead Product Candidates at ASCO Annual Meeting PHILLIPSBURG, N.J., May 30, 2007 /PRNewswire/ -- Celldex Therapeutics announced today that clinical data from studies with its two lead product candidates, CDX-110 and CDX-1307, will be presented during poster sessions at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). The ASCO meeting is being held at McCormick Place in Chicago, IL from Friday, June 1 through Tuesday, June 5. The CDX-110 poster "Temozolomide as a vaccine adjuvant in GBM" will be displayed during the "Central Nervous System Tumors" poster discussion session on Sunday, June 3, between 8:00 a.m. and 12:00 p.m. The CDX-1307 poster entitled "Antigen presenting cell (APC)-targeted hCG Beta vaccine for cancer therapy" will be on display during the "Developmental Therapeutics: Immunotherapy" poster discussion session on Sunday, June 3 between 2:00 p.m. and 6:00 p.m.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next